Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Start date: Oct 27, 2026 to Oct 28, 2026
  2. Minor Start date: Oct 26, 2026 to Oct 27, 2026
  3. Minor Start date: Oct 25, 2026 to Oct 26, 2026
  4. Minor Start date: Oct 22, 2026 to Oct 25, 2026
  5. Minor Start date: Oct 21, 2026 to Oct 22, 2026
Show 14 earlier versionsHide 14 earlier versions
  1. Minor Start date: Oct 20, 2026 to Oct 21, 2026
  2. Minor Start date: Oct 19, 2026 to Oct 20, 2026
  3. Minor Start date: Oct 18, 2026 to Oct 19, 2026
  4. Minor Start date: Oct 14, 2026 to Oct 18, 2026
  5. Minor Start date: Oct 13, 2026 to Oct 14, 2026
  6. Minor Start date: Oct 12, 2026 to Oct 13, 2026
  7. Minor Start date: Oct 11, 2026 to Oct 12, 2026
  8. Minor Start date: Oct 8, 2026 to Oct 11, 2026
  9. Minor Start date: Oct 7, 2026 to Oct 8, 2026
  10. Minor Start date: Oct 6, 2026 to Oct 7, 2026
  11. Minor Start date: Oct 5, 2026 to Oct 6, 2026
  12. Minor Start date: Oct 4, 2026 to Oct 5, 2026
  13. Minor Start date: Sep 20, 2026 to Oct 4, 2026
    • Eligibility criteria expanded, about 7 words
    • Publications: details revised at 2 of 2 entries
  14. Minor Start date: Sep 17, 2026 to Sep 20, 2026v10
  1. Minor Trial status changed: Recruiting → Not Yet Recruiting
    • Start date: Sep 16, 2026 to Sep 17, 2026
    v9
  2. Minor Start date: Sep 15, 2026 to Sep 16, 2026v8
  3. Notable Start date: Nov 1, 2023 to Sep 15, 2026
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised
    v7
  4. 5 versions Re-verified since Nov 9, 2023, no change to tracked fieldsv2-v6
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Infections in the lower respiratory tract (lungs) are the leading cause of death from infectious disease worldwide. This was true even before the COVID-19 pandemic. Respiratory viruses are still a major health threat. Many of these viruses infect people by penetrating the thin skin that lines the nose. These viruses can also spread easily to other people when they multiply in the tissues that line the nose. Researchers want to learn more about what these viruses do inside the nose, how they get from the nose to the lungs, and how they spread from person to person. Objective: To collect cell samples from inside the noses of healthy people. These cells will be stored for use in future research on respiratory diseases. Eligibility: Healthy volunteers aged 18 years and older. Design: Most participants will have 1 visit on 1 day. They will be asked questions. Those who have a runny nose, coughing, congestion, or fever will be asked to wait up to 21 days before participating. Participants will be given a slender swab with small bristles at the end. They will rub the inside of their nose with the swab. A clinic staff member will be present to help, if needed. Participants will provide their name, age, and sex. This information will be encoded so that only certain researchers will know the participants identities. Participants will not be contacted again....
Trial Details
NCT Number NCT06120244
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
(from sponsor)
Healthy
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov